Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prognostic Significance of EZH2 Expression in Non-Small Cell Lung Cancer: A Meta-analysis
Xinhua Wang, Hongqing Zhao, Lei Lv, et al.
Scientific Reports (2016) Vol. 6, Iss. 1
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Epigenetics in cancer stem cells
Tan Boon Toh, Jhin Jieh Lim, Edward Kai‐Hua Chow
Molecular Cancer (2017) Vol. 16, Iss. 1
Open Access | Times Cited: 369
Targeting histone methylation for cancer therapy: enzymes, inhibitors, biological activity and perspectives
Yongcheng Song, Fangrui Wu, Jingyu Wu
Journal of Hematology & Oncology (2016) Vol. 9, Iss. 1
Open Access | Times Cited: 137
Transcription regulation by biomolecular condensates
Gaofeng Pei, Heankel Lyons, Pilong Li, et al.
Nature Reviews Molecular Cell Biology (2024)
Closed Access | Times Cited: 12
MUC1-C activates polycomb repressive complexes and downregulates tumor suppressor genes in human cancer cells
Hasan Rajabi, Masayuki Hiraki, Donald Küfe
Oncogene (2018) Vol. 37, Iss. 16, pp. 2079-2088
Open Access | Times Cited: 64
Epigenetic regulation of cancer biology and anti-tumor immunity by EZH2
Anthos Christofides, Theodoros Karantanos, Kankana Bardhan, et al.
Oncotarget (2016) Vol. 7, Iss. 51, pp. 85624-85640
Open Access | Times Cited: 52
Long noncoding RNA DANCR regulates proliferation and migration by epigenetically silencing FBP1 in tumorigenesis of cholangiocarcinoma
Ni Wang, Chongguo Zhang, Wulin Wang, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 8
Open Access | Times Cited: 49
Inhibition of EZH2 via activation of SAPK/JNK and reduction of p65 and DNMT1 as a novel mechanism in inhibition of human lung cancer cells by polyphyllin I
Longmei Li, Jingjing Wu, Fang Zheng, et al.
Journal of Experimental & Clinical Cancer Research (2016) Vol. 35, Iss. 1
Open Access | Times Cited: 43
EZH2-mediated Puma gene repression regulates non-small cell lung cancer cell proliferation and cisplatin-induced apoptosis
Haidan Liu, Wěi Li, Xinfang Yu, et al.
Oncotarget (2016) Vol. 7, Iss. 35, pp. 56338-56354
Open Access | Times Cited: 43
MUC1-C activates EZH2 expression and function in human cancer cells
Hasan Rajabi, Masayuki Hiraki, Ashujit Tagde, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 41
Oncogenic roles of enhancer of zeste homolog 1/2 in hematological malignancies
Makoto Nakagawa, Issay Kitabayashi
Cancer Science (2018) Vol. 109, Iss. 8, pp. 2342-2348
Open Access | Times Cited: 40
EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells
Hao Gong, Li Y, Yuan Yin, et al.
BMC Cancer (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 36
The pharmacological and biological importance of EZH2 signaling in lung cancer
Maliheh Entezari, Afshin Taheriazam, Mahshid Deldar Abad Paskeh, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 160, pp. 114313-114313
Open Access | Times Cited: 13
Cisplatin-based Liposomal Nanocarriers for Drug Delivery in Lung Cancer Therapy: Recent Progress and Future Outlooks
Kave Mohammad-Jafari, Seyed Morteza Naghib, M. R. Mozafari
Current Pharmaceutical Design (2024) Vol. 30, Iss. 36, pp. 2850-2881
Closed Access | Times Cited: 4
miR-17-5p down-regulation contributes to erlotinib resistance in non-small cell lung cancer cells
Weihua Zhang, Jun Lin, Peng Wang, et al.
Journal of drug targeting (2016) Vol. 25, Iss. 2, pp. 125-131
Open Access | Times Cited: 32
A Perspective of Epigenetic Regulation in Radiotherapy
Peng Qin, Kegui Weng, Shitian Li, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 27
Exploring oncogenic roles and clinical significance of EZH2: focus on non-canonical activities
Michał Woźniak, Małgorzata Czyż
Therapeutic Advances in Medical Oncology (2025) Vol. 17
Open Access
The role of EZH2 in overall survival of colorectal cancer: a meta-analysis
Laura Vilorio-Marqués, Vicente Martín, Cristina Diez‐Tascón, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 29
Bimodal regulation of the PRC2 complex by USP7 underlies tumorigenesis
Dongxue Su, Wenjuan Wang, Yongqiang Hou, et al.
Nucleic Acids Research (2021) Vol. 49, Iss. 8, pp. 4421-4440
Open Access | Times Cited: 21
Aberrant Epigenetic Regulation in Head and Neck Cancer Due to Distinct EZH2 Overexpression and DNA Hypermethylation
Daiki Mochizuki, Yuki Misawa, Hideya Kawasaki, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 12, pp. 3707-3707
Open Access | Times Cited: 27
JMJD1A promotes tumorigenesis and forms a feedback loop with EZH2/let-7c in NSCLC cells
Min Zhan, Feiqiu Wen, Lijuan Liu, et al.
Tumor Biology (2016) Vol. 37, Iss. 8, pp. 11237-11247
Closed Access | Times Cited: 25
Correlation between EZH2 and CEP55 and lung adenocarcinoma prognosis
Shouming Wu, Duoguang Wu, Yingpeng Pan, et al.
Pathology - Research and Practice (2018) Vol. 215, Iss. 2, pp. 292-301
Closed Access | Times Cited: 25
Epigenetic Inactivation of the Tumor Suppressor IRX1 Occurs Frequently in Lung Adenocarcinoma and Its Silencing Is Associated with Impaired Prognosis
Miriam M. Küster, Marc A. Schneider, Antje Richter, et al.
Cancers (2020) Vol. 12, Iss. 12, pp. 3528-3528
Open Access | Times Cited: 21
Targeting EZH2 to overcome the resistance to immunotherapy in lung cancer
Daniel Sanghoon Shin, Kevin Park, Edward B. Garon, et al.
Seminars in Oncology (2022) Vol. 49, Iss. 3-4, pp. 306-318
Open Access | Times Cited: 13
Inhibition of EZH2 exerts antitumorigenic effects in renal cell carcinoma via LATS1
Seong Hwi Hong, Hyun Ji Hwang, Da Hyeon Son, et al.
FEBS Open Bio (2023) Vol. 13, Iss. 4, pp. 724-735
Open Access | Times Cited: 8
High methylation levels of histone H3 lysine 9 associated with activation of hypoxia-inducible factor 1α (HIF-1α) predict patients’ worse prognosis in human hepatocellular carcinomas
Yanyan Qian, Yiping Li, Chuqian Zheng, et al.
Cancer Genetics (2020) Vol. 245, pp. 17-26
Closed Access | Times Cited: 18
Page 1 - Next Page

Scroll to top